Article Text

Download PDFPDF

501 Anti-LG3 antibodies contribute to microvascular loss and fibrosis in lupus nephritis
  1. Marie-Hélene Normand1,2,3,
  2. Shanshan Lan2,3,4,
  3. Sandrine Juillard1,2,3,
  4. Julie Turgeon2,3,
  5. Annie Karakeussian-Rimbaud2,
  6. Francis Migneault2,3,
  7. Éric Boilard3,5,
  8. Guillaume Bollée2,4,
  9. Marie-Josée Hébert2,3,4 and
  10. Mélanie Dieudé1,2,3
  1. 1Département Microbiologie, Infectiologie et Immunologie, Faculté de Médecine, Université de Montréal
  2. 2Centre de Recherche du CHUM (CRCHUM)
  3. 3Canadian Donation and Transplantation Research Program (CDTRP)
  4. 4Université de Montréal
  5. 5Université Laval


Background Lupus nephritis (LN) is a common and serious manifestation of systemic lupus erythematosus (SLE) and 30% of cases, affected patients progress to end stage renal disease (ESRD). Microvascular damage is an emerging contributing factor to LN renal dysfunction leading to end stage renal disease. We have shown that vascular injury derived apoptotic exosomes can trigger SLE autoantibodies as well as autoantibodies targeting perlecan/LG3 (anti- LG3). We have also unraveled biomarkers and effector roles of anti-LG3 in kidney vascular damage in both native and transplanted kidneys. We hypothesize that anti-LG3 responses contribute to microvascular damage of importance in LN development.

Methods Longitudinal bleeds were performed on SLE prone NZB/NZWF1 and control mice. Circulating Anti-LG3 IgG levels were measured by ELISA. 26 weeks old NZB/NZWF1 mice were infused with anti-LG3 or control IgG, every second day for 3 weeks. Kidneys were harvested at sacrifice for renal histology and immunohistochemistry analyses. PTC capillary loss was evaluated with MECA-32 staining and renal interstitial fibrosis aSMA and Collagen IV staining.

Results Elevated levels of anti-LG3 are found in SLE prone mice, compared to control mice. Importantly, NZB/NZWF1 mice passively transferred with anti-LG3 exhibited significantly increased interstitial inflammation, PTC capillary loss, and renal interstitial fibrosis in the absence of glomerular abnormalities (crescents and proliferation), compared to mice transferred with control IgG.

Conclusions These observations suggest that anti-LG3 antibodies are elevated in SLE and show a tropism specific for the interstitial microvasculature, contributing to microvascular loss and fibrosis. A better understanding of the impact of these novel biomarkers and effector will improve identification, prediction, and management of LN.

This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See:

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.